CN1100425A - 噻唑并嘧啶衍生物 - Google Patents

噻唑并嘧啶衍生物 Download PDF

Info

Publication number
CN1100425A
CN1100425A CN94105279A CN94105279A CN1100425A CN 1100425 A CN1100425 A CN 1100425A CN 94105279 A CN94105279 A CN 94105279A CN 94105279 A CN94105279 A CN 94105279A CN 1100425 A CN1100425 A CN 1100425A
Authority
CN
China
Prior art keywords
carbon atoms
group
pyrimidine
thiazolo
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94105279A
Other languages
English (en)
Chinese (zh)
Inventor
松本裕生
田中纪子
中山清
茶谷晴子
岩花伦生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of CN1100425A publication Critical patent/CN1100425A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN94105279A 1993-04-01 1994-04-01 噻唑并嘧啶衍生物 Pending CN1100425A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP110877/93 1993-04-01
JP11087793 1993-04-01

Publications (1)

Publication Number Publication Date
CN1100425A true CN1100425A (zh) 1995-03-22

Family

ID=14546967

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94105279A Pending CN1100425A (zh) 1993-04-01 1994-04-01 噻唑并嘧啶衍生物

Country Status (9)

Country Link
US (1) US5599813A (2)
EP (1) EP0618208A1 (2)
CN (1) CN1100425A (2)
AU (1) AU672675B2 (2)
CA (1) CA2120395A1 (2)
FI (1) FI941487L (2)
NO (1) NO941135L (2)
PH (1) PH31256A (2)
TW (1) TW272193B (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103443107A (zh) * 2011-03-28 2013-12-11 弗·哈夫曼-拉罗切有限公司 噻唑并嘧啶化合物

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000022532A (ko) * 1996-06-27 2000-04-25 오노 야꾸힝 고교 가부시키가이샤 아릴(설파이드, 설폭시드 및 설폰)유도체 및 이를 활성 성분으로 함유하는 약물
ATE276763T1 (de) 1998-07-13 2004-10-15 Univ Texas Verwendung von antikörper gegen aminophospholipide zur krebsbehandlung
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
DE10112197A1 (de) * 2001-03-14 2002-09-19 Gruenenthal Gmbh Substituierte Pyrazolo- und Thiazolopyrimidine
EP2357009A1 (en) 2002-07-15 2011-08-17 Board of Regents, The University of Texas System Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
ES2809302T3 (es) 2004-01-22 2021-03-03 Univ Miami Formulaciones de coenzima Q10 para tratar tumores sólidos mediante administración intravenosa
KR20070064660A (ko) 2004-10-07 2007-06-21 베링거 인겔하임 인터내셔날 게엠베하 Pi3 키나제
ES2572356T3 (es) 2007-11-09 2016-05-31 Peregrine Pharmaceuticals Inc Composiciones de anticuerpos dirigidos contra VEGF y procedimientos
EP2633864A1 (en) 2008-07-25 2013-09-04 The Regents of the University of Colorado Clip inhibitors and methods of modulating immune function
CN101899058B (zh) * 2010-05-24 2012-05-23 中国人民解放军第四军医大学 一种噻唑并嘧啶化合物及其制备方法和应用
EP3576726A1 (en) 2017-02-06 2019-12-11 Massachusetts Institute Of Technology Methods and products related to glutaminase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52106893A (en) * 1976-01-19 1977-09-07 Diamond Shamrock Corp Antiiinflammation imidazothiazole and thiazolopyrimidine
FR2479831A1 (fr) * 1980-04-08 1981-10-09 Synthelabo Derives de thiazole, leur preparation et leur application en therapeutique
PL129375B1 (en) * 1980-07-24 1984-05-31 Rhone Poulenc Ind Process for preparing novel derivatives of 2,3,6,7-tetrahydro-thiazole-/3,2-a/-pyrimidin-5-one
US4347248A (en) * 1981-03-23 1982-08-31 American Cyanamid Company 2,3-Disubstituted-thiazolo[3,2-a]pyrimidines
US5082838A (en) * 1989-06-21 1992-01-21 Takeda Chemical Industries, Ltd. Sulfur-containing fused pyrimidine derivatives, their production and use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103443107A (zh) * 2011-03-28 2013-12-11 弗·哈夫曼-拉罗切有限公司 噻唑并嘧啶化合物
CN103443107B (zh) * 2011-03-28 2016-04-20 弗·哈夫曼-拉罗切有限公司 噻唑并嘧啶化合物

Also Published As

Publication number Publication date
FI941487A0 (fi) 1994-03-30
NO941135D0 (no) 1994-03-28
US5599813A (en) 1997-02-04
NO941135L (no) 1994-10-03
EP0618208A1 (en) 1994-10-05
TW272193B (2) 1996-03-11
FI941487A7 (fi) 1994-10-02
AU5925294A (en) 1994-10-06
FI941487L (fi) 1994-10-02
PH31256A (en) 1998-06-18
AU672675B2 (en) 1996-10-10
CA2120395A1 (en) 1994-10-02

Similar Documents

Publication Publication Date Title
CN1279023C (zh) 吲哚-3-硫衍生物
CN1031570C (zh) 吡唑并吡啶化合物的制备方法
CN1146566C (zh) 2-芳基-8-氧代二氢嘌呤衍生物及其制备方法、含该衍生物的药物组合物、及其中间体
CN1024667C (zh) 取代的氨甲基四氢化萘和取化氨甲基氢化苯并吡喃及其盐制备方法
CN1033088C (zh) 新的噻唑基苯并呋喃衍生物的制备方法
CN1040874C (zh) 三唑并哒嗪化合物及制备法和以该化合物作为活性成分的组合物
CN1149214C (zh) 三唑并衍生物和含有它们作为有效组分的趋化因子抑制剂
CN1671659A (zh) 新的取代吲哚
CN1826339A (zh) 2-酰氨基-4-苯基噻唑衍生物,其制备方法及其在治疗学上的应用
CN87105680A (zh) 咪唑化合物及其制备方法,和包含该化合物的药物组合物
CN1030252C (zh) 四氢苯并咪唑衍生物的制备方法
CN1906189A (zh) 用于治疗呼吸系统疾病的1-乙酸-吲哚、-吲唑和-苯并咪唑衍生物
CN1809560A (zh) 作为mtp抑制剂的噻唑基哌啶衍生物
CN1060841A (zh) 喹唑啉衍生物及其制备方法
CN1268133A (zh) 含有稠合环取代基的作为nos抑制剂的2-氨基吡啶
CN1653062A (zh) 作为nmda受体阻断剂的(咪唑-1-基-甲基)-哒嗪
CN1055182A (zh) N-(吡咯并《2,3-d》嘧啶-3-基酰基)-谷氨酸衍生物
CN1077954A (zh) 新的苯并吡喃衍生物
CN1738806A (zh) 氧代-氮杂双环化合物
CN1152879C (zh) 萘啶衍生物
CN1305467A (zh) 二氮杂萘衍生物磷酸二酯酶4抑制剂
CN1100425A (zh) 噻唑并嘧啶衍生物
CN101065376A (zh) 2-酰胺基-4-苯基噻唑衍生物、它们的制备与治疗应用
CN1745065A (zh) 4-氧代-3-(1-氧代-1h-异喹啉-2-基乙酰氨基)-戊酸酯和酰胺衍生物及其作为天冬氨酸特异性半胱氨酸蛋白酶抑制剂的用途
CN1956982A (zh) 具有氨基噻唑骨架的Cdk4、6选择性抑制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication